FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to treatment of infectious diseases, and can be used in correction of electrolyte disorders in patients with coronavirus infection COVID-19. Method involves examination of patients, infusion of preparations of potassium chloride and sodium chloride, assessment of blood cortisol, blood ACTH, potassium and sodium. Before the beginning of the treatment, the blood cortisol level, blood ACTH level, potassium and sodium levels are determined, which respectively have the following values: sodium 130.35 ± 6.5 mmol/l, potassium 3.7 ± 0.6 mmol/l, blood cortisol 454.7 ± 138.5 nmol/l, ACTH 14.8 ± 6.6 nmol/l. If the sodium level is below 135 mmol/l and the potassium level is below 3.5 mmol/l, electrolyte disturbances are corrected by intravenous infusions of potassium and sodium preparations, and if ineffective, hydrocortisone 10 mg is administered orally. Duration of hydrocortisone intake is determined by calculation model of hydrocortisone intake by ACTH level y = 2.6 + 0.08x, where y is the number of days of taking hydrocortisone required to stabilize electrolyte disturbances, x is the level of ACTH, and according to the calculated model of the length of taking hydrocortisone by the level of cortisol by the formula y = 3.3 + 0.001x, where y is the duration of taking hydrocortisone, x is blood cortisol level. 3 days after discontinuation of hydrocortisone and 7 days before discharge from hospital, a control measurement of potassium and sodium levels is performed to control the absence of hypokalaemia and recovery of electrolyte disturbances.
EFFECT: using the invention enables normalizing and restoring electrolyte disturbances in patients with COVID-19.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSIS OF IODINE-DEFICIENCY AND IODINE-INDUCED THYROID DYSFUNCTION IN INDIVIDUALS LIVING IN REGIONS WITH IODINE DEFICIENCY | 2019 |
|
RU2728261C2 |
METHOD OF INDIVIDUAL RECOVERY OF FUNCTIONAL ACTIVITY OF ADRENAL CORTEX IN PATIENTS WITH SOMATIC DISEASES WITH LONG HISTORY OF GLUCOCORTICOSTEROID THERAPY | 2010 |
|
RU2439563C1 |
METHOD FOR ASSESSING THE RISK OF DISTURBED HORMONE-FORMING FUNCTION DIRECTLY IN THE THYROID GLAND | 2019 |
|
RU2706500C1 |
KURNIKOVA'S METHOD OF DEFINING BIOLOGICAL COMPONENT OF REHABILITATION POTENTIAL FOR DIABETES PATIENTS | 2007 |
|
RU2344751C1 |
METHOD FOR EVALUATION OF FUNCTIONAL RESERVES OF BODY | 2007 |
|
RU2342900C1 |
METHOD FOR DETERMINING AND CALCULATING THE NECESSARY REQUIRED INSULIN DOSE FOR TYPE SECONDARY DIABETES AND FORMED INSULIN DEPENDENCE | 2018 |
|
RU2684393C1 |
METHOD FOR EARLY DIAGNOSIS OF PRIMARY HYPOTHYROIDISM | 2019 |
|
RU2722740C1 |
METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
METHOD OF PREVENTING ENDOTHELIAL DAMAGE IN CRITICALLY ILL PATIENTS | 2023 |
|
RU2812594C1 |
METHOD FOR DETERMINING PROBABILITY OF ACTH-ECTOPIC SYNDROME IN PATIENTS WITH ACTH-DEPENDENT ENDOGENOUS HYPERADRENOCORTICISM | 2023 |
|
RU2814146C1 |
Authors
Dates
2024-08-07—Published
2023-05-07—Filed